During the flurry of new releases and PR for the Healthcare spin off several analysts mentioned that CBG was the next candidate for spin off/sale from 3M. An analyst from JP Morgan mentioned the poor performance and lackluster sales results for CBG. P&G as well as Kimberly Clark were mentioned as possibilities. It has been a bit over 4 months with the new CEO but many coworkers I know are just silently waiting for some form of big changes in CBG. It is just a matter of time.
Bumping this up so it’s not lost in replies.
Source: @ypf+1uF3dDNz